Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2006
The purpose of this study is to determine the safety of and immune response to a DNA HIV vaccine, pGA2/JS7, followed by a modified vaccinia (smallpox) HIV vaccine, MVA/HIV62, in HIV uninfected adults.
Epistemonikos ID: 5ef6de2f13109b85f8630726cbfe82f0fa24efea
First added on: Dec 01, 2021